Literature DB >> 1426176

Clusters of meningococcal disease in France (1987-1988).

R Olivares1, B Hubert.   

Abstract

We analyzed 814 cases of meningococcal disease notified in 1987 and 1988 to the Ministry of Health. Data were obtained by report forms including informations about possible additional cases among contacts. Coprimary cases (occurring within 24 hours after the index case) and secondary cases (occurring more than 24 hours after index case) were all reviewed. Twenty eight clusters of meningococcal disease were identified involving 65 cases (8% of total cases). Twelve of the 814 cases (1.5%) were coprimary cases of an index case and 25 (3%) were secondary cases. The secondary attack rate was 530/100,000 among household contacts and 31/100,000 among school contacts. Seventy two per cent of the secondary cases occurred in the first week after index case. Thirty-eight percent of the secondary cases occurred in the 15-20 age group as opposed to 15% of single cases. Serogroup A was more often found in coprimary (33%) and secondary cases (17%) than in single cases (6%). In France, prophylaxis of secondary cases is administered to the classroom contacts of a case of meningococcal infection but is not required for the entire school except under epidemic conditions.

Entities:  

Mesh:

Year:  1992        PMID: 1426176     DOI: 10.1007/bf00145393

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  15 in total

1.  Control of meningococcal disease.

Authors:  D M Jones
Journal:  BMJ       Date:  1989-03-04

2.  Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1984-7.

Authors:  R P Cooke; T Riordan; D M Jones; M J Painter
Journal:  BMJ       Date:  1989-03-04

3.  Spread of meningococcal infection within households.

Authors:  R S Munford; A de E Taunay; J S de Morais; D W Fraser; R A Feldman
Journal:  Lancet       Date:  1974-06-22       Impact factor: 79.321

4.  Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis.

Authors: 
Journal:  J Infect Dis       Date:  1976-08       Impact factor: 5.226

5.  Epidemic meningococcal disease in an elementary-school classroom.

Authors:  R D Feigin; C J Baker; L A Herwaldt; R M Lampe; E O Mason; S E Whitney
Journal:  N Engl J Med       Date:  1982-11-11       Impact factor: 91.245

6.  Seroepidemiology and chemoprophylaxis disease due to sulfonamide-resistant Neisseria meningitidis in a civillian population.

Authors:  A B Kaiser; C H Hennekens; M S Saslaw; P S Hayes; J V Bennett
Journal:  J Infect Dis       Date:  1974-09       Impact factor: 5.226

7.  Meningococcal disease. Secondary attack rate and chemoprophylaxis in the United States, 1974.

Authors: 
Journal:  JAMA       Date:  1976-01-19       Impact factor: 56.272

8.  Prevention of secondary cases of meningococcal disease in household contacts by vaccination.

Authors:  B M Greenwood; M Hassan-King; H C Whittle
Journal:  Br Med J       Date:  1978-05-20

9.  Meningococcal disease in Belgium. Secondary attack rate among household, day-care nursery and pre-elementary school contacts.

Authors:  P De Wals; L Hertoghe; I Borlée-Grimée; S De Maeyer-Cleempoel; G Reginster-Haneuse; A Dachy; A Bouckaert; M F Lechat
Journal:  J Infect       Date:  1981-03       Impact factor: 6.072

10.  An outbreak of meningococcal disease in Gloucestershire.

Authors:  K A Cartwright; J M Stuart; N D Noah
Journal:  Lancet       Date:  1986-09-06       Impact factor: 79.321

View more
  8 in total

1.  Managing meningococcal disease case clusters: art or science?

Authors:  K Ardern; S Bowler; R M Hussey; C M Regan
Journal:  J Epidemiol Community Health       Date:  1999-09       Impact factor: 3.710

2.  Evidence for indirect nosocomial transmission of Neisseria meningitidis resulting in two cases of invasive meningococcal disease.

Authors:  Johannes Elias; Heike Claus; Matthias Frosch; Ulrich Vogel
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

3.  Secondary cases of meningococcal disease.

Authors:  A J Pollard; R Booy; S Nadel; M Levin
Journal:  Arch Dis Child       Date:  1996-12       Impact factor: 3.791

4.  Antibiotic prescribing during an outbreak of meningococcal disease.

Authors:  J M Stuart; P M Robinson; K Cartwright; N D Noah
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

Review 5.  An epidemiological review of changes in meningococcal biology during the last 100 years.

Authors:  Anne Abio; Keith R Neal; Charles R Beck
Journal:  Pathog Glob Health       Date:  2013-12-19       Impact factor: 2.894

6.  Space-time cluster analysis of invasive meningococcal disease.

Authors:  Christian J P A Hoebe; Hester de Melker; Lodewijk Spanjaard; Jacob Dankert; Nico Nagelkerke
Journal:  Emerg Infect Dis       Date:  2004-09       Impact factor: 6.883

7.  Vaccine preventability of meningococcal clone, Greater Aachen Region, Germany.

Authors:  Johannes Elias; Leo M Schouls; Ingrid van de Pol; Wendy C Keijzers; Diana R Martin; Anne Glennie; Philipp Oster; Matthias Frosch; Ulrich Vogel; Arie van der Ende
Journal:  Emerg Infect Dis       Date:  2010-03       Impact factor: 6.883

8.  Spatiotemporal analysis of invasive meningococcal disease, Germany.

Authors:  Johannes Elias; Dag Harmsen; Heike Claus; Wiebke Hellenbrand; Matthias Frosch; Ulrich Vogel
Journal:  Emerg Infect Dis       Date:  2006-11       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.